<?xml version="1.0" encoding="UTF-8"?>
<p id="p0045">At the beginning, due to the unknown nature of this emergent virus, all diagnosis was based purely on clinical and radiographic findings (i.e., bilateral infiltrates on chest imaging), failure of antibiotic therapy, and exclusion of other common respiratory infections (
 <xref rid="bib20" ref-type="bibr">Huang et al., 2020</xref>; 
 <xref rid="bib75" ref-type="bibr">Zhu et al., 2020</xref>). Now, laboratory detection includes next-generation sequencing platforms, reverse-transcription polymerase chain reaction (RT-PCR), and serological methods like enzyme-linked immunoassay. Generally, a patient should be taken into account for laboratory detection if his or her clinical manifestations and/or radiographical records are positive. From the most common symptoms to the least—these are not constant—for COVID-19 fever, fatigue, dry cough, anorexia, myalgias, dyspnea, and sputum production are known so far (
 <xref rid="bib61" ref-type="bibr">Wang et al., 2020b</xref>). Recently, anosmia and dysgeusia have been added to this list as common symptoms (
 <xref rid="bib14" ref-type="bibr">Giacomelli et al., 2020</xref>). In addition, some less common complaints are headache, sore throat, rhinorrhea, and gastrointestinal disorders (e.g., nausea and diarrhea) (
 <xref rid="bib7" ref-type="bibr">Chen et al., 2020a</xref>).
</p>
